Team:ETH Zurich/Modeling/Overview
From 2008.igem.org
Luca.Gerosa (Talk | contribs) |
Luca.Gerosa (Talk | contribs) |
||
Line 43: | Line 43: | ||
<div style="text-align:justify;"> | <div style="text-align:justify;"> | ||
'''Questions:''' <br> | '''Questions:''' <br> | ||
- | * Is it possible to slow growth of large genome strains by using a thymidine | + | * Is it possible to slow growth of large genome strains by using a thymidine auxotrophyc strain and limiting thymidine feeding? |
- | * What is the best restriction enzyme to be used in order to maximize genome reduction and at the same time vitality (growth rate) of thymidine | + | * What is the best restriction enzyme to be used in order to maximize genome reduction and at the same time vitality (growth rate) of thymidine auxotrophyc strains? |
+ | * What is the predicted genome reduction difference if the medium is minimal or very rich in term of nutrients? | ||
* Which are the predicted quantitative differences in terms of growth rate and genome size of strains on which has been applied the selection procedure? | * Which are the predicted quantitative differences in terms of growth rate and genome size of strains on which has been applied the selection procedure? | ||
<br><br> | <br><br> |
Revision as of 16:01, 11 October 2008
Overview on the modelling frameworkThis page is meant to give an introduction to the the overall modelling framework we have constructed in order to asses feasibility analysis, temporal scale details and other parameter estimations that regard our project setup. As introduced in the project overview section, four main components can be identified in the deviced mechanism. Accordingly, we divided the modelling framework in four modules that tackles the relative problematics.
|